ANX5; ENX2; PP4; PAP-I; CBP-I; Anchorin CII; Calphobindin I; Endonexin II; Lipocortin V; Placental anticoagulant protein 4; Thromboplastin inhibitor; Vascular anticoagulant-alpha
ANX5; ENX2; PP4; PAP-I; CBP-I; Anchorin CII; Calphobindin I; Endonexin II; Lipocortin V; Placental anticoagulant protein 4; Thromboplastin inhibitor; Vascular anticoagulant-alpha
TNFRSF5; CDW40; Bp50; P50; B-cell surface antigen CD40; CD40L receptor
TNFRSF5; CDW40; Bp50; P50; B-cell surface antigen CD40; CD40L receptor
CD304; BDCA4; VEGF165R; Vascular endothelial cell growth factor 165 receptor
CD304; BDCA4; VEGF165R; Vascular endothelial cell growth factor 165 receptor
SMR; MPF; CAK1; Pre-pro-megakaryocyte-potentiating factor; Megakaryocyte-potentiating factor
SMR; MPF; CAK1; Pre-pro-megakaryocyte-potentiating factor; Megakaryocyte-potentiating factor
CD354; Triggering Receptor Expressed On Monocytes-1
CD354; Triggering Receptor Expressed On Monocytes-1